PERSPECTA

News from every angle

← Back to headlines

Praxis Precision Medicines Misses Q4 GAAP EPS Estimates

Praxis Precision Medicines reported a GAAP EPS of -$3.50, missing analyst estimates by $0.40.

19 Feb, 12:37 — 19 Feb, 12:37

PostShare